NCT01994746View on ClinicalTrials.gov

Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Nasal Glucagon

DRUG

Intramuscular Glucagon

Trial Locations (8)

14222

UPA Buffalo, Buffalo

19104

University of Pennsylvania, Philadelphia

32605

University of Florida, Gainesville

46202

Riley Hospital for Children Indiana University Health, Indianapolis

55454

University of Minnesota, Minneapolis

80045

Barbara Davis Center for Diabetes, Aurora

97239

Oregon Health and Science University, Portland

06520

Yale University, New Haven

Sponsors

Collaborators (1)

Locemia Solutions ULC
All Listed Sponsors
collaborator

T1D Exchange Clinic Network Coordinating Center

UNKNOWN

collaborator

Locemia Solutions ULC

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY

NCT01994746 - Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults | Biotech Hunter | Biotech Hunter